Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Howard Weiner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Anatomy

Physiology

Procedures

Oral Administration

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sampat M P; Berger A M; Healy B C; Hildenbrand P; Vass J; Meier D S; Chitnis T; Weiner H L; Bakshi R; Guttmann C R G
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
Farez Mauricio F; Quintana Francisco J; Gandhi Roopali; Izquierdo Guillermo; Lucas Miguel; Weiner Howard L
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
Zota Victor; Nemirovsky Anna; Baron Rona; Fisher Yair; Selkoe Dennis J; Altmann Daniel M; Weiner Howard L; Monsonego Alon
HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Howard Weiner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sampat M P; Berger A M; Healy B C; Hildenbrand P; Vass J; Meier D S; Chitnis T; Weiner H L; Bakshi R; Guttmann C R G
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
AJNR. American journal of neuroradiology 2009;30(9):1731-9.
2009: Farez Mauricio F; Quintana Francisco J; Gandhi Roopali; Izquierdo Guillermo; Lucas Miguel; Weiner Howard L
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
Nature immunology 2009;10(9):958-64.
2009: Zota Victor; Nemirovsky Anna; Baron Rona; Fisher Yair; Selkoe Dennis J; Altmann Daniel M; Weiner Howard L; Monsonego Alon
HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(5):3522-30.
2009: Gauthier S A; Glanz B I; Mandel M; Tsagkaropoulos Antonios; Neema Mohit; Stankiewicz James; Arora Ashish; Duan Yang; Liptak Zsuzsanna; Egorova Svetlana; Buckle Guy J; Bakshi Rohit; Guttmann C R G; Khoury S J; Weiner H L
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
Journal of the neurological sciences 2009;284(1-2):116-9.
2009: Murugaiyan Gopal; Mittal Akanksha; Lopez-Diego Rocio; Maier Lisa M; Anderson David E; Weiner Howard L
IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2435-43.
2009: Healy Brian C; Ali Eman N; Guttmann Charles R G; Chitnis Tanuja; Glanz Bonnie I; Buckle Guy; Houtchens Maria; Stazzone Lynn; Moodie Jennifer; Berger Annika M; Duan Yang; Bakshi Rohit; Khoury Samia; Weiner Howard; Ascherio Alberto
Smoking and disease progression in multiple sclerosis.
Archives of neurology 2009;66(7):858-64.
2009: De Jager Philip L; Jia Xiaoming; Wang Joanne; de Bakker Paul I W; Ottoboni Linda; Aggarwal Neelum T; Piccio Laura; Raychaudhuri Soumya; Tran Dong; Aubin Cristin; Briskin Rebeccah; Romano Susan; Baranzini Sergio E; McCauley Jacob L; Pericak-Vance Margaret A; Haines Jonathan L; Gibson Rachel A; Naeglin Yvonne; Uitdehaag Bernard; Matthews Paul M; Kappos Ludwig; Polman Chris; McArdle Wendy L; Strachan David P; Evans Denis; Cross Anne H; Daly Mark J; Compston Alastair; Sawcer Stephen J; Weiner Howard L; Hauser Stephen L; Hafler David A; Oksenberg Jorge R
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
Nature genetics 2009;41(7):776-82.
2009: Frenkel Dan; Pachori Alok S; Zhang Lunan; Dembinsky-Vaknin Adi; Farfara Dorit; Petrovic-Stojkovic Sanja; Dzau Victor J; Weiner Howard L
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.
International immunology 2009;21(7):817-29.
2009: Kivisäkk P; Healy B C; Viglietta V; Quintana F J; Hootstein M A; Weiner H L; Khoury S J
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
Neurology 2009;72(22):1922-30.
2009: Weiner Howard L
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
Annals of neurology 2009;65(3):239-48.
2009: Ali E N; Healy B C; Stazzone L A; Brown B A; Weiner H L; Khoury S J
Daclizumab in treatment of multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(2):272-4.
2008: Viglietta V; Bourcier K; Buckle G J; Healy B; Weiner H L; Hafler D A; Egorova S; Guttmann C R G; Rusche J R; Khoury S J
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.
Neurology 2008;71(12):917-24.
2008: Liptak Z; Berger A M; Sampat M P; Charil A; Felsovalyi O; Healy B C; Hildenbrand P; Khoury S J; Weiner H L; Bakshi R; Guttmann C R G
Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.
AJNR. American journal of neuroradiology 2008;29(8):1465-70.
2008: Quintana Francisco J; Farez Mauricio F; Weiner Howard L
Systems biology approaches for the study of multiple sclerosis.
Journal of cellular and molecular medicine 2008;12(4):1087-93.
2008: De Jager Philip L; Rossin Elizabeth; Pyne Saumyadipta; Tamayo Pablo; Ottoboni Linda; Viglietta Vissia; Weiner Mira; Soler Dulce; Izmailova Elena; Faron-Yowe Lauren; O'Brien Carmeline; Freeman Sam; Granados Susana; Parker Alex; Roubenoff Ronenn; Mesirov Jill P; Khoury Samia J; Hafler David A; Weiner Howard L
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells.
Brain : a journal of neurology 2008;131(Pt 7):1701-11.
2008: Chen Mei-Ling; Yan Bo-Shiun; Bando Yoshio; Kuchroo Vijay K; Weiner Howard L
Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(11):7327-37.
2008: Quintana Francisco J; Basso Alexandre S; Iglesias Antonio H; Korn Thomas; Farez Mauricio F; Bettelli Estelle; Caccamo Mario; Oukka Mohamed; Weiner Howard L
Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor.
Nature 2008;453(7191):65-71.
2008: Frenkel Dan; Puckett Lindsay; Petrovic Sanja; Xia Weiming; Chen Guiquan; Vega Jose; Dembinsky-Vaknin Adi; Shen Jie; Plante Martin; Burt David S; Weiner Howard L
A nasal proteosome adjuvant activates microglia and prevents amyloid deposition.
Annals of neurology 2008;63(5):591-601.
2008: Basso Alexandre S; Frenkel Dan; Quintana Francisco J; Costa-Pinto Frederico A; Petrovic-Stojkovic Sanja; Puckett Lindsay; Monsonego Alon; Bar-Shir Amnon; Engel Yoni; Gozin Michael; Weiner Howard L
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
The Journal of clinical investigation 2008;118(4):1532-43.
2008: Vaknin-Dembinsky Adi; Murugaiyan Gopal; Hafler David A; Astier Anne L; Weiner Howard L
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.
Journal of neuroimmunology 2008;195(1-2):140-5.
2008: Vaknin-Dembinsky Adi; Brass Steven D; Gandhi Roopali; Weiner Howard L
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.
Journal of neuroimmunology 2008;195(1-2):135-9.
2008: Weiner Howard L
A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis.
Journal of neurology 2008;255 Suppl 1():3-11.
2008: Sayegh Mohamed H; Weiner Howard L
Regulating rejection with cell therapy.
Nature biotechnology 2008;26(2):191-2.
2008: Abraham Michal; Karni Arnon; Dembinsky Adi; Miller Ariel; Gandhi Roopali; Anderson David; Weiner Howard L
In vitro induction of regulatory T cells by anti-CD3 antibody in humans.
Journal of autoimmunity 2008;30(1-2):21-8.
2007: Awasthi Amit; Carrier Yijun; Peron Jean P S; Bettelli Estelle; Kamanaka Masahito; Flavell Richard A; Kuchroo Vijay K; Oukka Mohamed; Weiner Howard L
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.
Nature immunology 2007;8(12):1380-9.
2007: Meier D S; Weiner H L; Guttmann C R G
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
AJNR. American journal of neuroradiology 2007;28(10):1956-63.
2007: Glanz B I; Holland C M; Gauthier S A; Amunwa E L; Liptak Z; Houtchens M K; Sperling R A; Khoury S J; Guttmann C R G; Weiner H L
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(8):1004-10.
2007: Vaknin-Dembinsky Adi; Weiner Howard L
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapy.
Journal of the neurological sciences 2007;259(1-2):90-4.
2007: Ishikawa Hiroki; Ochi Hirofumi; Chen Mei-Ling; Frenkel Dan; Maron Ruth; Weiner Howard L
Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
Diabetes 2007;56(8):2103-9.
2007: Meier Dominik S; Weiner Howard L; Guttmann Charles R G
Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential?
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2007;4(3):485-98.
2007: Gauthier S A; Mandel M; Guttmann C R G; Glanz B I; Khoury S J; Betensky R A; Weiner H L
Predicting short-term disability in multiple sclerosis.
Neurology 2007;68(24):2059-65.
2007: Kappos Ludwig; Bates David; Hartung Hans-Peter; Havrdova Eva; Miller David; Polman Chris H; Ravnborg Mads; Hauser Stephen L; Rudick Richard A; Weiner Howard L; O'Connor Paul W; King John; Radue Ernst Wilhelm; Yousry Tarek; Major Eugene O; Clifford David B
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring.
Lancet neurology 2007;6(5):431-41.
2007: Gandhi Roopali; Anderson David E; Weiner Howard L
Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(7):4017-21.
2007: Carrier Yijun; Yuan Jing; Kuchroo Vijay K; Weiner Howard L
Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(1):179-85.
2007: Carrier Yijun; Yuan Jing; Kuchroo Vijay K; Weiner Howard L
Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(1):172-8.
2006: Gauthier Susan A; Glanz Bonnie I; Mandel Micha; Weiner Howard L
A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study.
Autoimmunity reviews 2006;5(8):532-6.
2006: Rawle F E; Pratt K P; Labelle A; Weiner H L; Hough C; Lillicrap D
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2172-9.
2006: Karni Arnon; Abraham Michal; Monsonego Alon; Cai Guifang; Freeman Gordon J; Hafler David; Khoury Samia J; Weiner Howard L
Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):4196-202.
2006: Faria Ana M C; Weiner Howard L
Oral tolerance and TGF-beta-producing cells.
Inflammation & allergy drug targets 2006;5(3):179-90.
2006: Oida Takatoku; Xu Lili; Weiner Howard L; Kitani Atsushi; Strober Warren
TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2331-9.
2006: Laplaud David-Axel; Berthelot Laureline; Miqueu Patrick; Bourcier Kasia; Moynard Julien; Oudinet Yannick; Guillet Marina; Ruiz Catherine; Oden Neal; Brouard Sophie; Guttmann Charles R G; Weiner Howard L; Khoury Samia J; Soulillou Jean-Paul
Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
Journal of neuroimmunology 2006;177(1-2):151-60.
2006: Faria Ana M C; Weiner Howard L
Oral tolerance: therapeutic implications for autoimmune diseases.
Clinical & developmental immunology 2006;13(2-4):143-57.
2006: Vaknin-Dembinsky Adi; Balashov Konstantin; Weiner Howard L
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7768-74.
2006: Ochi Hirofumi; Abraham Michal; Ishikawa Hiroki; Frenkel Dan; Yang Kaiyong; Basso Alexandre S; Wu Henry; Chen Mei-Ling; Gandhi Roopali; Miller Ariel; Maron Ruth; Weiner Howard L
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
Nature medicine 2006;12(6):627-35.
2006: Bettelli Estelle; Carrier Yijun; Gao Wenda; Korn Thomas; Strom Terry B; Oukka Mohamed; Weiner Howard L; Kuchroo Vijay K
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Nature 2006;441(7090):235-8.
2006: Weiner Howard L; Frenkel Dan
Immunology and immunotherapy of Alzheimer's disease.
Nature reviews. Immunology 2006;6(5):404-16.
2006: Hauser Stephen L; Weiner Howard L
Natalizumab: immune effects and implications for therapy.
Annals of neurology 2006;59(5):731-2.
2006: Quintana Francisco J; Weiner Howard L
Understanding natural and pathological autoimmunity.
Journal of neuroimmunology 2006;174(1-2):1-2.
2006: Zhang Xingmin; Reddy Jayagopala; Ochi Hirofumi; Frenkel Dan; Kuchroo Vijay K; Weiner Howard L
Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
International immunology 2006;18(4):495-503.
2006: Monsonego Alon; Imitola Jaime; Petrovic Sanja; Zota Victor; Nemirovsky Anna; Baron Rona; Fisher Yair; Owens Trevor; Weiner Howard L
Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(13):5048-53.
2006: Gonnella Patricia A; Chen Youhai H; Waldner Hanspeter; Weiner Howard L
Induction of oral tolerization in CD86 deficient mice: a role for CD86 and B cells in the up-regulation of TGF-beta.
Journal of autoimmunity 2006;26(2):73-81.
2006: Wu Henry Yim; Monsonego Alon; Weiner Howard L
The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Journal of autoimmunity 2006;26(2):116-26.
2005: Miyamoto Katsuichi; Kingsley Cherry I; Zhang Xingmin; Jabs Claudia; Izikson Leonid; Sobel Raymond A; Weiner Howard L; Kuchroo Vijay K; Sharpe Arlene H
The ICOS molecule plays a crucial role in the development of mucosal tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(11):7341-7.
2005: Frohman Elliot M; Stüve Olaf; Havrdova Eva; Corboy John; Achiron Anat; Zivadinov Robert; Sorensen Per Soelberg; Phillips J Theodore; Weinshenker Brian; Hawker Kathleen; Hartung Hans-Peter; Steinman Lawrence; Zamvil Scott; Cree Bruce A C; Hauser Stephen; Weiner Howard; Racke Michael K; Filippi Massimo
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Archives of neurology 2005;62(10):1519-30.
2005: Smith D R; Weinstock-Guttman B; Cohen J A; Wei X; Gutmann C; Bakshi R; Olek M; Stone L; Greenberg S; Stuart D; Orav J; Stuart W; Weiner H
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):573-82.
2005: Frenkel Dan; Maron Ruth; Burt David S; Weiner Howard L
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.
The Journal of clinical investigation 2005;115(9):2423-33.
2005: Gauthier S A; Weiner H L
Cyclophosphamide therapy for MS.
International MS journal / MS Forum 2005;12(2):52-8.
2005: Faria Ana M C; Weiner Howard L
Oral tolerance.
Immunological reviews 2005;206():232-59.
2005: Frenkel Dan; Huang Zhihong; Maron Ruth; Koldzic Djordje N; Moskowitz Michael A; Weiner Howard L
Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke.
Journal of the neurological sciences 2005;233(1-2):125-32.
2005: Abraham Michal; Shapiro Sarah; Karni Arnon; Weiner Howard L; Miller Ariel
Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells.
Journal of neuroimmunology 2005;163(1-2):157-64.
2005: Prat Alexandre; Biernacki Katarzyna; Saroli Tanya; Orav John E; Guttmann Charles R G; Weiner Howard L; Khoury Samia J; Antel Jack P
Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability.
Archives of neurology 2005;62(5):795-800.
2005: Gauthier Susan A; Buckle Guy J; Weiner Howard L
Immunosuppressive therapy for multiple sclerosis.
Neurologic clinics 2005;23(1):247-72, viii-ix.
2004: Weiner Howard L
Current issues in the treatment of human diseases by mucosal tolerance.
Annals of the New York Academy of Sciences 2004;1029():211-24.
2004: Gonnella Patricia A; Waldner Hans Peter; Kodali Dhatri; Weiner Howard L
Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis.
Journal of autoimmunity 2004;23(3):193-200.
2004: Hara Hideo; Monsonego Alon; Yuasa Katsutoshi; Adachi Kayo; Xiao Xiao; Takeda Shin'ichi; Takahashi Keikichi; Weiner Howard L; Tabira Takeshi
Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2004;6(5):483-8.
2004: Weiner Howard L
Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
Archives of neurology 2004;61(10):1613-5.
2004: Cai Guifang; Karni Arnon; Oliveira Enedina M L; Weiner Howard L; Hafler David A; Freeman Gordon J
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells.
Cellular immunology 2004;230(2):89-98.
2004: Hommes O R; Weiner H L
Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.
Journal of the neurological sciences 2004;223(1):65-7.
2004: Weiner Howard L
Immunosuppressive treatment in multiple sclerosis.
Journal of the neurological sciences 2004;223(1):1-11.
2004: Meier Dominik S; Weiner Howard L; Khoury Samia J; Guttmann Charles R G
Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2004;14(3 Suppl):46S-53S.
2004: Viglietta Vissia; Baecher-Allan Clare; Weiner Howard L; Hafler David A
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.
The Journal of experimental medicine 2004;199(7):971-9.
2004: Zhang Xingmin; Koldzic Djordje N; Izikson Leonid; Reddy Jayagopala; Nazareno Remedios F; Sakaguchi Shimon; Kuchroo Vijay K; Weiner Howard L
IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
International immunology 2004;16(2):249-56.
2004: Karni Arnon; Balashov Konstantin; Hancock Wayne W; Bharanidharan Padmanabhan; Abraham Michal; Khoury Samia J; Weiner Howard L
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Journal of neuroimmunology 2004;146(1-2):189-98.
2004: Klein Robyn S; Izikson Leonid; Means Terry; Gibson Hilary D; Lin Eugene; Sobel Raymond A; Weiner Howard L; Luster Andrew D
IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):550-9.
2003: Frenkel Dan; Huang Zhihong; Maron Ruth; Koldzic Djordje N; Hancock Wayne W; Moskowitz Michael A; Weiner Howard L
Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(12):6549-55.
2003: Monsonego Alon; Weiner Howard L
Immunotherapeutic approaches to Alzheimer's disease.
Science (New York, N.Y.) 2003;302(5646):834-8.
2003: Monsonego Alon; Beserman Zur P; Kipnis Jonathan; Yoles Eti; Weiner Howard L; Schwartz Michal
Beneficial effect of orally administered myelin basic protein in EAE-susceptible Lewis rats in a model of acute CNS degeneration.
Journal of autoimmunity 2003;21(2):131-8.
2003: Monsonego Alon; Imitola Jaime; Zota Victor; Oida Takatoku; Weiner Howard L
Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(5):2216-24.
2003: Monsonego Alon; Zota Victor; Karni Arnon; Krieger Jeffery I; Bar-Or Amit; Bitan Gal; Budson Andrew E; Sperling Reisa; Selkoe Dennis J; Weiner Howard L
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.
The Journal of clinical investigation 2003;112(3):415-22.
2003: Bettelli Estelle; Pagany Maria; Weiner Howard L; Linington Christopher; Sobel Raymond A; Kuchroo Vijay K
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.
The Journal of experimental medicine 2003;197(9):1073-81.
2003: Hopfer Helmut; Maron Ruth; Butzmann Ulrike; Helmchen Udo; Weiner Howard L; Kalluri Raghu
The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(8):860-8.
2003: Faria Ana M C; Maron Ruth; Ficker Sabine M; Slavin Anthony J; Spahn Thomas; Weiner Howard L
Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis.
Journal of autoimmunity 2003;20(2):135-45.
2003: Oida Takatoku; Zhang Xingmin; Goto Masao; Hachimura Satoshi; Totsuka Mamoru; Kaminogawa Shuichi; Weiner Howard L
CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2516-22.
2003: Gonnella Patricia A; Kodali Dhatri; Weiner Howard L
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2316-22.
2003: Cotton Francois; Weiner Howard L; Jolesz Ferenc A; Guttmann Charles R G
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
Neurology 2003;60(4):640-6.
2003: Wu Henry Yim; Weiner Howard L
Oral tolerance.
Immunologic research 2003;28(3):265-84.
2002: Weiner Howard L; Selkoe Dennis J
Inflammation and therapeutic vaccination in CNS diseases.
Nature 2002;420(6917):879-84.
2002: Spahn Thomas W; Herbst Hermann; Rennert Paul D; Lügering Norbert; Maaser Christian; Kraft Mathias; Fontana Adriano; Weiner Howard L; Domschke Wolfram; Kucharzik Torsten
Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.
The American journal of pathology 2002;161(6):2273-82.
2002: Maron Ruth; Sukhova Galina; Faria Ana-Maria; Hoffmann Ethan; Mach Francois; Libby Peter; Weiner Howard L
Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice.
Circulation 2002;106(13):1708-15.
2002: Soos Jeanne M; Stüve Olaf; Youssef Sawsan; Bravo Manuel; Johnson Howard M; Weiner Howard L; Zamvil Scott S
Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2231-5.
2002: Izikson Leonid; Klein Robyn S; Luster Andrew D; Weiner Howard L
Targeting monocyte recruitment in CNS autoimmune disease.
Clinical immunology (Orlando, Fla.) 2002;103(2):125-31.
2002: Comabella Manuel; Imitola Jaime; Weiner Howard L; Khoury Samia J
Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients.
Journal of neuroimmunology 2002;126(1-2):205-12.
2002: Weiner H L; Cohen J A
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):142-54.
2002: Hommes O R; Weiner H L
Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):139-41.
2002: Karni Arnon; Koldzic Djordje N; Bharanidharan Padmanabhan; Khoury Samia J; Weiner Howard L
IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions.
Journal of neuroimmunology 2002;125(1-2):134-40.
2002: Spahn Thomas W; Weiner Howard L; Rennert Paul D; Lügering Norbert; Fontana Adriano; Domschke Wolfram; Kucharzik Torsten
Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.
European journal of immunology 2002;32(4):1109-13.
2002: Wei Xingchang; Warfield Simon K; Zou Kelly H; Wu Ying; Li Xiaoming; Guimond Alexandre; Mugler John P; Benson Randall R; Wolfson Leslie; Weiner Howard L; Guttmann Charles R G
Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy.
Journal of magnetic resonance imaging : JMRI 2002;15(2):203-9.
2002: Maron Ruth; Slavin Anthony J; Hoffmann Ethan; Komagata Yoshinori; Weiner Howard L
Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
International immunology 2002;14(2):131-8.
2002: Makhlouf Karim; Weiner Howard L; Khoury Samia J
Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).
CNS drugs 2002;16(1):1-8.
2001: Lemere C A; Maron R; Selkoe D J; Weiner H L
Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease.
DNA and cell biology 2001;20(11):705-11.
2001: Slavin A J; Soos J M; Stuve O; Patarroyo J C; Weiner H L; Fontana A; Bikoff E K; Zamvil S S
Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.
The Journal of clinical investigation 2001;108(8):1133-9.
2001: Zhang X; Izikson L; Liu L; Weiner H L
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(8):4245-53.
2001: Weiner H L
Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.
Microbes and infection / Institut Pasteur 2001;3(11):947-54.
2001: Makhlouf K; Weiner H L; Khoury S J
Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS.
Journal of neuroimmunology 2001;119(1):145-9.
2001: Weiner H L
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
Immunological reviews 2001;182():207-14.
2001: Monsonego A; Maron R; Zota V; Selkoe D J; Weiner H L
Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10273-8.
2001: Weiner H L
The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells.
Nature immunology 2001;2(8):671-2.
2001: Makhlouf K; Comabella M; Imitola J; Weiner H L; Khoury S J
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.
Journal of neuroimmunology 2001;117(1-2):156-65.
2001: Slavin A J; Maron R; Weiner H L
Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes.
International immunology 2001;13(6):825-33.
2001: Yoles E; Hauben E; Palgi O; Agranov E; Gothilf A; Cohen A; Kuchroo V; Cohen I R; Weiner H; Schwartz M
Protective autoimmunity is a physiological response to CNS trauma.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(11):3740-8.
2001: Spahn T W; Fontana A; Faria A M; Slavin A J; Eugster H P; Zhang X; Koni P A; Ruddle N H; Flavell R A; Rennert P D; Weiner H L
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.
European journal of immunology 2001;31(4):1278-87.
2001: Gonnella P A; Waldner H P; Weiner H L
B cell-deficient (mu MT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(7):4456-64.
2001: Weiner H L
The fine line between autoimmune and allergic encephalomyelitis.
Nature immunology 2001;2(3):193-4.
2001: Encinas J A; Lees M B; Sobel R A; Symonowicz C; Weiner H L; Seidman C E; Seidman J G; Kuchroo V K
Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis.
International immunology 2001;13(3):257-64.
2001: Maron R; Guerau-de-Arellano M; Zhang X; Weiner H L
Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
Journal of autoimmunity 2001;16(1):21-8.
2001: Sperling R A; Guttmann C R; Hohol M J; Warfield S K; Jakab M; Parente M; Diamond E L; Daffner K R; Olek M J; Orav E J; Kikinis R; Jolesz F A; Weiner H L
Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.
Archives of neurology 2001;58(1):115-21.
2000: Weiner H L
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
The Journal of clinical investigation 2000;106(8):935-7.
2000: Weiner H L; Lemere C A; Maron R; Spooner E T; Grenfell T J; Mori C; Issazadeh S; Hancock W W; Selkoe D J
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
Annals of neurology 2000;48(4):567-79.
2000: Izikson L; Klein R S; Charo I F; Weiner H L; Luster A D
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.
The Journal of experimental medicine 2000;192(7):1075-80.
2000: Rottman J B; Slavin A J; Silva R; Weiner H L; Gerard C G; Hancock W W
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent.
European journal of immunology 2000;30(8):2372-7.
2000: Khoury S J; Guttmann C R; Orav E J; Kikinis R; Jolesz F A; Weiner H L
Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.
Archives of neurology 2000;57(8):1183-9.
2000: Balashov K E; Comabella M; Ohashi T; Khoury S J; Weiner H L
Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
Neurology 2000;55(2):192-8.
2000: Weiner H L; Guttmann C R; Khoury S J; Orav E J; Hohol M J; Kikinis R; Jolesz F A
Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage.
Journal of neuroimmunology 2000;104(2):164-73.
2000: Komagata Y; Weiner H L
Oral tolerance.
Reviews in immunogenetics 2000;2(1):61-73.
2000: Lemere C A; Maron R; Spooner E T; Grenfell T J; Mori C; Desai R; Hancock W W; Weiner H L; Selkoe D J
Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.
Annals of the New York Academy of Sciences 2000;920():328-31.
1999: Hohol M J; Olek M J; Orav E J; Stazzone L; Hafler D A; Khoury S J; Dawson D M; Weiner H L
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(6):403-9.
1999: Karussis D; Weiner H L; Abramsky O
Multiple sclerosis vs Lyme disease: a case presentation to a discussant and a review of the literature.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(6):395-402.
1999: Weiner H L
Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.
The Journal of clinical investigation 1999;104(12):1667-8.
1999: Spahn T W; Issazadah S; Salvin A J; Weiner H L
Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene.
European journal of immunology 1999;29(12):4060-71.
1999: Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner H L; Kelley V R
IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6884-91.
1999: Garcia G; Komagata Y; Slavin A J; Maron R; Weiner H L
Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Journal of autoimmunity 1999;13(3):315-24.
1999: Hohol M J; Orav E J; Weiner H L
Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(5):349-54.
1999: Khoury S J; Orav E J; Guttmann C R; Kikinis R; Jolesz F A; Weiner H L
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
Neurology 1999;53(4):758-64.
1999: Maron R; Hancock W W; Slavin A; Hattori M; Kuchroo V; Weiner H L
Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
International immunology 1999;11(9):1573-80.
1999: Liu L; Kuchroo V K; Weiner H L
B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(4):2284-90.
1999: Hattori M; Yamato E; Itoh N; Senpuku H; Fujisawa T; Yoshino M; Fukuda M; Matsumoto E; Toyonaga T; Nakagawa I; Petruzzelli M; McMurray A; Weiner H; Sagai T; Moriwaki K; Shiroishi T; Maron R; Lund T
Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(4):1721-4.
1999: Weiner H L; van Rees E P
Mucosal tolerance.
Immunology letters 1999;69(1):3-4.
1999: Balashov K E; Rottman J B; Weiner H L; Hancock W W
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(12):6873-8.
1999: Maron R; Melican N S; Weiner H L
Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Journal of autoimmunity 1999;12(4):251-8.
1999: Kikinis R; Guttmann C R; Metcalf D; Wells W M; Ettinger G J; Weiner H L; Jolesz F A
Quantitative follow-up of patients with multiple sclerosis using MRI: technical aspects.
Journal of magnetic resonance imaging : JMRI 1999;9(4):519-30.
1999: Guttmann C R; Kikinis R; Anderson M C; Jakab M; Warfield S K; Killiany R J; Weiner H L; Jolesz F A
Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility.
Journal of magnetic resonance imaging : JMRI 1999;9(4):509-18.
1999: Kappos L; Moeri D; Radue E W; Schoetzau A; Schweikert K; Barkhof F; Miller D; Guttmann C R; Weiner H L; Gasperini C; Filippi M
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
Lancet 1999;353(9157):964-9.
1999: Weiner H L
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3333-5.
1999: Encinas J A; Wicker L S; Peterson L B; Mukasa A; Teuscher C; Sobel R; Weiner H L; Seidman C E; Seidman J G; Kuchroo V K
QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2.
Nature genetics 1999;21(2):158-60.
1999: Faria A M; Weiner H L
Oral tolerance: mechanisms and therapeutic applications.
Advances in immunology 1999;73():153-264.
1999: Garcia G; Weiner H L
Manipulation of Th responses by oral tolerance.
Current topics in microbiology and immunology 1999;238():123-45.
1998: Chen W; Jin W; Cook M; Weiner H L; Wahl S M
Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(11):6297-304.
1998: Kuchroo V K; Weiner H L
Antigen-driven regulation of experimental autoimmune encephalomyelitis.
Research in immunology 1998;149(9):759-71; discussion 842-3, 855-60.
1998: Windhagen A; Anderson D E; Carrizosa A; Balashov K; Weiner H L; Hafler D A
Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
Journal of neuroimmunology 1998;91(1-2):1-9.
1998: Balashov K E; Olek M J; Smith D R; Khoury S J; Weiner H L
Seasonal variation of interferon-gamma production in progressive multiple sclerosis.
Annals of neurology 1998;44(5):824-8.
1998: Bettelli E; Das M P; Howard E D; Weiner H L; Sobel R A; Kuchroo V K
IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3299-306.
1998: Zamvil S S; Soos J M; Weiner H L
Pathogenesis and treatment of central nervous system demyelinating disease.
Revue neurologique 1998;154(8-9):573-5.
1998: Inobe J; Slavin A J; Komagata Y; Chen Y; Liu L; Weiner H L
IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
European journal of immunology 1998;28(9):2780-90.
1998: Liu L; Rich B E; Inobe J; Chen W; Weiner H L
Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4.
International immunology 1998;10(8):1017-26.
1998: Comabella M; Balashov K; Issazadeh S; Smith D; Weiner H L; Khoury S J
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
The Journal of clinical investigation 1998;102(4):671-8.
1998: Takashima H; Smith D R; Fukaura H; Khoury S J; Hafler D A; Weiner H L
Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.
Clinical immunology and immunopathology 1998;88(1):28-34.
1998: Weiner H L
A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1998;25(2):93-101.
1998: Gonnella P A; Chen Y; Inobe J; Komagata Y; Quartulli M; Weiner H L
In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(10):4708-18.
1998: Maron R; Palanivel V; Weiner H L; Harn D A
Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice.
Clinical immunology and immunopathology 1998;87(1):85-92.
1998: Chen Y; Hancock W W; Marks R; Gonnella P; Weiner H L
Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.
Journal of neuroimmunology 1998;82(2):149-59.
1998: Khoury S J; Weiner H L
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
Archives of internal medicine 1998;158(6):565-73.
1998: Weiner H L; Komagata Y
Oral tolerance and the treatment of rheumatoid arthritis.
Springer seminars in immunopathology 1998;20(1-2):289-308.
1998: Liu L M; Weiner H L
T-cell response to orally administered antigens and its role in the treatment of autoimmune diseases.
Chemical immunology 1998;71():139-60.
1997: Hafler D A; Kent S C; Pietrusewicz M J; Khoury S J; Weiner H L; Fukaura H
Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.
Annals of the New York Academy of Sciences 1997;835():120-31.
1997: Smith D R; Weiner H L
Immunologic aspects of neurologic and neuromuscular diseases.
JAMA : the journal of the American Medical Association 1997;278(22):1956-61.
1997: Weiner H L; Gonnella P A; Slavin A; Maron R
Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines.
Research in immunology 1997;148(8-9):528-33.
1997: Smith D R; Balashov K E; Hafler D A; Khoury S J; Weiner H L
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Annals of neurology 1997;42(3):313-8.
1997: Hohol M J; Guttmann C R; Orav J; Mackin G A; Kikinis R; Khoury S J; Jolesz F A; Weiner H L
Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.
Archives of neurology 1997;54(8):1018-25.
1997: Polanski M; Melican N S; Zhang J; Weiner H L
Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.
Journal of autoimmunity 1997;10(4):339-46.
1997: Weiner H L
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
Immunology today 1997;18(7):335-43.
1997: Chen Y; Inobe J; Weiner H L
Inductive events in oral tolerance in the TCR transgenic adoptive transfer model.
Cellular immunology 1997;178(1):62-8.
1997: Kent S C; Fukaura H; Pietrusewicz M J; Khoury S J; Weiner H L; Hafler D A
Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in multiple sclerosis patients.
Annals of the New York Academy of Sciences 1997;815():412-22.
1997: Balashov K E; Smith D R; Khoury S J; Hafler D A; Weiner H L
Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):599-603.
1997: Fowler E; Weiner H L
Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
Biopolymers 1997;43(4):323-35.
1997: Liu L; Rich B E; Inobe J; Chen W; Weiner H L
A potential pathway of Th2 development during primary immune response. IL-10 pretreated dendritic cells can prime naive CD4+ T cells to secrete IL-4.
Advances in experimental medicine and biology 1997;417():375-81.
1997: Weiner H L
Oral tolerance for the treatment of autoimmune diseases.
Annual review of medicine 1997;48():341-51.
1996: Encinas J A; Weiner H L; Kuchroo V K
Inheritance of susceptibility to experimental autoimmune encephalomyelitis.
Journal of neuroscience research 1996;45(6):655-69.
1996: Encinas J A; Lees M B; Sobel R A; Symonowicz C; Greer J M; Shovlin C L; Weiner H L; Seidman C E; Seidman J G; Kuchroo V K
Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):2186-92.
1996: al-Sabbagh A M; Goad E P; Weiner H L; Nelson P A
Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis.
Journal of neuroscience research 1996;45(4):424-9.
1996: Fukaura H; Kent S C; Pietrusewicz M J; Khoury S J; Weiner H L; Hafler D A
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
The Journal of clinical investigation 1996;98(1):70-7.
1996: al-Sabbagh A; Nelson P A; Akselband Y; Sobel R A; Weiner H L
Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
Cellular immunology 1996;171(1):111-9.
1996: Olek M J; Hohol M J; Weiner H L
Methotrexate in the treatment of multiple sclerosis.
Annals of neurology 1996;39(5):684.
1996: Matsui M; Hafler D A; Weiner H L
Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency.
Annals of the New York Academy of Sciences 1996;778():398-404.
1996: Inobe J I; Chen Y; Weiner H L
In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis.
Annals of the New York Academy of Sciences 1996;778():390-2.
1996: Akselband Y; Hoffer T L; Nelson P A; Gonnella P A; Weiner H L
Local and systemic immune responses in SJL/J mice during prolonged oral myelin basic protein administration.
Annals of the New York Academy of Sciences 1996;778():358-61.
1996: Maron R; Blogg N S; Polanski M; Hancock W; Weiner H L
Oral tolerance to insulin and the insulin B-chain: cell lines and cytokine patterns.
Annals of the New York Academy of Sciences 1996;778():346-57.
1996: Sayegh M H; Khoury S J; Hancock W W; Weiner H L; Carpenter C B
Mechanisms of oral tolerance by MHC peptides.
Annals of the New York Academy of Sciences 1996;778():338-45.
1996: Fukaura H; Kent S C; Pietrusewicz M J; Khoury S J; Weiner H L; Hafler D A
Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
Annals of the New York Academy of Sciences 1996;778():251-7.
1996: Hohol M J; Khoury S J; Cook S L; Orav E J; Hafler D A; Weiner H L
Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.
Annals of the New York Academy of Sciences 1996;778():243-50.
1996: Nelson P A; Akselband Y; Dearborn S M; Al-Sabbagh A; Tian Z J; Gonnella P A; Zamvil S S; Chen Y; Weiner H L
Effect of oral beta interferon on subsequent immune responsiveness.
Annals of the New York Academy of Sciences 1996;778():145-55.
1996: Chen Y H; Weiner H L
Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance.
Annals of the New York Academy of Sciences 1996;778():111-21.
1996: Weiner H L; Mayer L F
Oral tolerance: mechanisms and applications. Introduction.
Annals of the New York Academy of Sciences 1996;778():xiii-xviii.
1996: Chen Y; Inobe J; Kuchroo V K; Baron J L; Janeway C A; Weiner H L
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):388-91.
1996: Windhagen A; Nicholson L B; Weiner H L; Kuchroo V K; Hafler D A
Role of Th1 and Th2 cells in neurologic disorders.
Chemical immunology 1996;63():171-86.
1995: Hancock W W; Polanski M; Zhang J; Blogg N; Weiner H L
Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
The American journal of pathology 1995;147(5):1193-9.
1995: Weiner H L
Oral tolerance: mobilizing the gut.
Hospital practice (1995) 1995;30(9):53-8.
1995: Yoshino S; Quattrocchi E; Weiner H L
Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen.
Arthritis and rheumatism 1995;38(8):1092-6.
1995: Khoury S J; Gallon L; Chen W; Betres K; Russell M E; Hancock W W; Carpenter C B; Sayegh M H; Weiner H L
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
The Journal of experimental medicine 1995;182(2):357-66.
1995: Chen Y; Inobe J; Marks R; Gonnella P; Kuchroo V K; Weiner H L
Peripheral deletion of antigen-reactive T cells in oral tolerance.
Nature 1995;376(6536):177-80.
1995: Chen Y; Inobe J; Weiner H L
Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(2):910-6.
1995: Balashov K E; Khoury S J; Hafler D A; Weiner H L
Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.
The Journal of clinical investigation 1995;95(6):2711-9.
1995: Hafler D A; Weiner H L
Immunologic mechanisms and therapy in multiple sclerosis.
Immunological reviews 1995;144():75-107.
1995: Kuchroo V K; Das M P; Brown J A; Ranger A M; Zamvil S S; Sobel R A; Weiner H L; Nabavi N; Glimcher L H
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
Cell 1995;80(5):707-18.
1995: Hohol M J; Orav E J; Weiner H L
Disease steps in multiple sclerosis: a simple approach to evaluate disease progression.
Neurology 1995;45(2):251-5.
1995: Weiner H L; Hohol M J; Khoury S J; Dawson D M; Hafler D A
Therapy for multiple sclerosis.
Neurologic clinics 1995;13(1):173-96.
1995: Prabhu Das M R; Zamvil S S; Borriello F; Weiner H L; Sharpe A H; Kuchroo V K
Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation.
European journal of immunology 1995;25(1):207-11.
1995: Hafler D A; Weiner H L
Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease.
Chemical immunology 1995;60():126-49.
1995: Hafler D A; Weiner H L
Antigen specific therapies for the treatment of autoimmune diseases.
Agents and actions. Supplements 1995;47():59-77.
1995: Weiner H L; Miller A; Khoury S J; Zhang Z J; al-Sabbagh A; Brod S A; Lider O; Higgins P; Sobel R; Matsui M
Treatment of autoimmune diseases by oral tolerance to autoantigens.
Advances in experimental medicine and biology 1995;371B():1217-23.
1995: Hafler D A; Weiner H L
Antigen-specific therapies for the treatment of autoimmune diseases.
Springer seminars in immunopathology 1995;17(1):61-76.
1994: Weiner H L
Oral tolerance.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(23):10762-5.
1994: Khoury S J; Guttmann C R; Orav E J; Hohol M J; Ahn S S; Hsu L; Kikinis R; Mackin G A; Jolesz F A; Weiner H L
Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden.
Neurology 1994;44(11):2120-4.
1994: Fishman-Lobell J; Friedman A; Weiner H L
Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice.
European journal of immunology 1994;24(11):2720-4.
1994: al-Sabbagh A; Miller A; Santos L M; Weiner H L
Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
European journal of immunology 1994;24(9):2104-9.
1994: Santos L M; al-Sabbagh A; Londono A; Weiner H L
Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
Cellular immunology 1994;157(2):439-47.
1994: Chen Y; Kuchroo V K; Inobe J; Hafler D A; Weiner H L
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
Science (New York, N.Y.) 1994;265(5176):1237-40.
1994: Friedman A; Weiner H L
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(14):6688-92.
1994: Khoury S J; Weiner H L
Kappa light chains in spinal fluid for diagnosing multiple sclerosis.
JAMA : the journal of the American Medical Association 1994;272(3):242-3.
1994: Kuchroo V K; Collins M; al-Sabbagh A; Sobel R A; Whitters M J; Zamvil S S; Dorf M E; Hafler D A; Seidman J G; Weiner H L
T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.
The Journal of experimental medicine 1994;179(5):1659-64.
1994: Miller A; Lider O; Abramsky O; Weiner H L
Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
European journal of immunology 1994;24(5):1026-32.
1994: Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner H L; Hafler D A
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
The Journal of experimental medicine 1994;179(3):973-84.
1994: Weiner H L; Friedman A; Miller A; Khoury S J; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt R B; Trentham D E; Hafler D A
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Annual review of immunology 1994;12():809-37.
1994: Friedman A; al-Sabbagh A; Santos L M; Fishman-Lobell J; Polanski M; Das M P; Khoury S J; Weiner H L
Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens.
Chemical immunology 1994;58():259-90.
1994: Zamvil S S; al-Sabbagh A; Nelson P A; Kaul D; Charles M S; Mitchell D J; Steinman L; Weiner H L; Kuchroo V K
'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis.
Pathobiology : journal of immunopathology, molecular and cellular biology 1994;62(3):113-9.
1993: Miller A; al-Sabbagh A; Santos L M; Das M P; Weiner H L
Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):7307-15.
1993: Trentham D E; Dynesius-Trentham R A; Orav E J; Combitchi D; Lorenzo C; Sewell K L; Hafler D A; Weiner H L
Effects of oral administration of type II collagen on rheumatoid arthritis.
Science (New York, N.Y.) 1993;261(5129):1727-30.
1993: Khoury S J; Sayegh M H; Hancock W W; Gallon L; Carpenter C B; Weiner H L
Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
The Journal of experimental medicine 1993;178(2):559-66.
1993: Miller A; Zhang Z J; Sobel R A; al-Sabbagh A; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
Journal of neuroimmunology 1993;46(1-2):73-82.
1993: Abromson-Leeman S; Hayashi M; Martin C; Sobel R; al-Sabbagh A; Weiner H; Dorf M E
T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice.
Journal of neuroimmunology 1993;45(1-2):89-101.
1993: Hancock W W; Sayegh M H; Kwok C A; Weiner H L; Carpenter C B
Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Transplantation 1993;55(5):1112-8.
1993: Weiner H L; Mackin G A; Orav E J; Hafler D A; Dawson D M; LaPierre Y; Herndon R; Lehrich J R; Hauser S L; Turel A
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Neurology 1993;43(5):910-8.
1993: Oettinger H F; al-Sabbagh A; Jingwu Z; LaSalle J M; Weiner H L; Hafler D A
Biological activity of recombinant human myelin basic protein.
Journal of neuroimmunology 1993;44(2):157-62.
1993: Hafler D A; Zhang J W; LaSalle J; Donnelly C; Weiner H L; Wucherpfeffnig K
The development of antigen specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis.
Clinical and experimental rheumatology 1993;11 Suppl 8():S39-40.
1993: Sayegh M H; Khoury S J; Hancock W W; Weiner H L; Carpenter C B
Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the rat.
Transplantation proceedings 1993;25(1 Pt 1):357-8.
1993: Weiner H L; Mackin G A; Matsui M; Orav E J; Khoury S J; Dawson D M; Hafler D A
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.
Science (New York, N.Y.) 1993;259(5099):1321-4.
1993: Weiner H L
Treatment of autoimmune diseases by oral tolerance to autoantigens.
Autoimmunity 1993;15 Suppl():6-7.
1992: Khoury S J; Hancock W W; Weiner H L
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
The Journal of experimental medicine 1992;176(5):1355-64.
1992: Sayegh M H; Khoury S J; Hancock W W; Weiner H L; Carpenter C B
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(16):7762-6.
1992: Miller A; Lider O; al-Sabbagh A; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
Journal of neuroimmunology 1992;39(3):243-50.
1992: Hafler D A; Cohen I; Benjamin D S; Weiner H L
T cell vaccination in multiple sclerosis: a preliminary report.
Clinical immunology and immunopathology 1992;62(3):307-13.
1992: Sayegh M H; Zhang Z J; Hancock W W; Kwok C A; Carpenter C B; Weiner H L
Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen.
Transplantation 1992;53(1):163-6.
1992: Miller A; Lider O; Roberts A B; Sporn M B; Weiner H L
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):421-5.
1992: Zhang J; Weiner H L; Hafler D A
Autoreactive T cells in multiple sclerosis.
International reviews of immunology 1992;9(3):183-201.
1991: Miller A; Hafler D A; Weiner H L
Immunotherapy in autoimmune diseases.
Current opinion in immunology 1991;3(6):936-40.
1991: Weiner H L; Zhang Z J; Khoury S J; Miller A; al-Sabbagh A; Brod S A; Lider O; Higgins P; Sobel R; Nussenblatt R B
Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens.
Annals of the New York Academy of Sciences 1991;636():227-32.
1991: Hafler D A; Matsui M; Wucherpfennig K W; Ota K; Weiner H L
The potential of restricted T cell recognition of myelin basic protein epitopes in the therapy of multiple sclerosis.
Annals of the New York Academy of Sciences 1991;636():251-65.
1991: Zhang Z J; Davidson L; Eisenbarth G; Weiner H L
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(22):10252-6.
1991: Miller A; Lider O; Weiner H L
Antigen-driven bystander suppression after oral administration of antigens.
The Journal of experimental medicine 1991;174(4):791-8.
1991: Miller A; Hafler D A; Weiner H L
Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(11):2560-6.
1991: Wucherpfennig K W; Weiner H L; Hafler D A
T-cell recognition of myelin basic protein.
Immunology today 1991;12(8):277-82.
1991: Brod S A; al-Sabbagh A; Sobel R A; Hafler D A; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Annals of neurology 1991;29(6):615-22.
1991: Hafler D A; Orav J; Gertz R; Stazzone L; Weiner H L
Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis.
Journal of neuroimmunology 1991;32(2):149-58.
1991: Zamaroczy D; Schluesener H J; Jolesz F A; Sobel R A; Colucci V M; Weiner H L; Sandor T
Differentiation of experimental white matter lesions using multiparametric magnetic resonance measurements.
Investigative radiology 1991;26(4):317-24.
1991: Lee S J; Wucherpfennig K W; Brod S A; Benjamin D; Weiner H L; Hafler D A
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis.
Annals of neurology 1991;29(1):33-40.
1991: Hafler D A; Chofflon M; Kurt-Jones E; Weiner H L
Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis.
Clinical immunology and immunopathology 1991;58(1):115-25.
1990: Toms R; Weiner H L; Johnson D
Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains.
Journal of neuroimmunology 1990;30(2-3):169-77.
1990: Khoury S J; Lider O; al-Sabbagh A; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
Cellular immunology 1990;131(2):302-10.
1990: Zhang Z Y; Lee C S; Lider O; Weiner H L
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2489-93.
1990: Ota K; Matsui M; Milford E L; Mackin G A; Weiner H L; Hafler D A
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Nature 1990;346(6280):183-7.
1990: Wucherpfennig K W; Ota K; Endo N; Seidman J G; Rosenzweig A; Weiner H L; Hafler D A
Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.
Science (New York, N.Y.) 1990;248(4958):1016-9.
1990: Santos L M; Lider O; Audette J; Khoury S J; Weiner H L
Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells.
Cellular immunology 1990;127(1):26-34.
1990: Weiner H L; Dau P C; Khatri B O; Petajan J; Birnbaum G; McQuillen M P; Fosburg M T; Feldstein M; Orav J
Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
Progress in clinical and biological research 1990;337():283.
1990: Wucherpfennig K W; Weiner H L
Immunologic mechanisms in chronic demyelinating diseases of the central and peripheral nervous system.
Research publications - Association for Research in Nervous and Mental Disease 1990;68():105-16.
1989: Seeldrayers P A; Yasui D; Weiner H L; Johnson D
Treatment of experimental allergic neuritis with nedocromil sodium.
Journal of neuroimmunology 1989;25(2-3):221-6.
1989: Chofflon M; González V; Weiner H L; Hafler D A
Inflammatory cerebrospinal fluid T cells have activation requirements characteristic of CD4+CD45RA- T cells.
European journal of immunology 1989;19(10):1791-5.
1989: Weiner H L; Dau P C; Khatri B O; Petajan J H; Birnbaum G; McQuillen M P; Fosburg M T; Feldstein M; Orav E J
Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis.
Neurology 1989;39(9):1143-9.
1989: Weiner H L; Paty D W
Diagnostic and therapeutic trials in multiple sclerosis: a new look. Summary of Jekyll Island workshop.
Neurology 1989;39(7):972-6.
1989: Chofflon M; Weiner H L; Morimoto C; Hafler D A
Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
Annals of neurology 1989;25(5):494-9.
1989: Duby A D; Weiner H L; Benjamin D S; Seidman J G; Hafler D A
Sequestration of virus-specific T cells in the cerebrospinal fluid of a patient with varicella zoster viral meningoencephalitis.
Journal of neuroimmunology 1989;22(1):63-8.
1989: Hafler D A; Brod S A; Weiner H L
Immunoregulation in multiple sclerosis.
Research in immunology 1989;140(2):233-9; discussion 245-8.
1989: Lider O; Santos L M; Lee C S; Higgins P J; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):748-52.
1988: Shepley M P; Sherry B; Weiner H L
Monoclonal antibody identification of a 100-kDa membrane protein in HeLa cells and human spinal cord involved in poliovirus attachment.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(20):7743-7.
1988: Chofflon M; Weiner H L; Morimoto C; Hafler D A
Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.
Annals of neurology 1988;24(2):185-91.
1988: Hafler D A; Weiner H L
Immunosuppression with monoclonal antibodies in multiple sclerosis.
Neurology 1988;38(7 Suppl 2):42-7.
1988: Carter J L; Hafler D A; Dawson D M; Orav J; Weiner H L
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Neurology 1988;38(7 Suppl 2):9-14.
1988: Schluesener H J; Sobel R A; Weiner H L
Demyelinating experimental allergic encephalomyelitis (EAE) in the rat: treatment with a monoclonal antibody against activated T cells.
Journal of neuroimmunology 1988;18(4):341-51.
1988: Hafler D A; Ritz J; Schlossman S F; Weiner H L
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):131-8.
1988: Hafler D A; Duby A D; Lee S J; Benjamin D; Seidman J G; Weiner H L
Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.
The Journal of experimental medicine 1988;167(4):1313-22.
1988: Sobel R A; Hafler D A; Castro E E; Morimoto C; Weiner H L
The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(7):2210-4.
1988: Weiner H L; Hafler D A
Immunotherapy of multiple sclerosis.
Annals of neurology 1988;23(3):211-22.
1988: Johnson D; Seeldrayers P A; Weiner H L
The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation.
Brain research 1988;444(1):195-8.
1988: Higgins P J; Weiner H L
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(2):440-5.
1988: Schluesener H J; Wucherpfennig K W; Weiner H L
Gene activation during experimental allergic encephalomyelitis. Cloning of new cDNAs.
Annals of the New York Academy of Sciences 1988;540():264-5.
1988: Johnson D; Weiner H L; Seeldrayers P A
Role of mast cells in peripheral nervous system demyelination.
Annals of the New York Academy of Sciences 1988;540():727-8.
1988: Hafler D A; Weiner H L
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human antimouse responses.
Annals of the New York Academy of Sciences 1988;540():557-9.
1988: Chofflon M; Weiner H L; Hafler D A
Loss of functional suppression is linked to decreases in circulating suppressor-inducer (CD4+ 2H4+) T cells in multiple sclerosis.
Annals of the New York Academy of Sciences 1988;540():330-2.
1988: Sobel R A; Hafler D A; Castro E E; Morimoto C; Weiner H L
Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue.
Annals of the New York Academy of Sciences 1988;540():306-8.
1988: Carter J L; Dawson D M; Hafler D A; Fallis R J; Stazzone L; Orav J; Weiner H L
Cumulative experience with high-dose intravenous cyclophosphamide and ACTH therapy in chronic progressive multiple sclerosis.
Annals of the New York Academy of Sciences 1988;540():535-6.
1987: Schluesener H J; Sobel R A; Linington C; Weiner H L
A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(12):4016-21.
1987: Hafler D A; Weiner H L
T cells in multiple sclerosis and inflammatory central nervous system diseases.
Immunological reviews 1987;100():307-32.
1987: Hauser S L; Che M; Fallis R J; Weiner H L
Immunoregulatory abnormalities induced by experimental reovirus infection: functional alterations in T-cell subpopulations.
Clinical immunology and immunopathology 1987;45(3):481-90.
1987: Hafler D A; Fox D A; Benjamin D; Blue M L; Weiner H L
Secondary immune amplification following live poliovirus immunization in humans.
Clinical immunology and immunopathology 1987;44(3):321-8.
1987: Hafler D A; Weiner H L
In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis.
Annals of neurology 1987;22(1):89-93.
1987: Hafler D A; Benjamin D S; Burks J; Weiner H L
Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):68-72.
1987: Fallis R J; Powers M L; Weiner H L
Serial analysis of peripheral blood T-cell phenotypes and myelin basic protein reactivity in experimental allergic encephalomyelitis.
Neurology 1987;37(4):719-23.
1987: Dawson D M; Carter J L; Hafler D A; Weiner H L
Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
Rivista di neurologia 1987;57(2):88-91.
1987: Fallis R J; Powers M L; Sy M S; Weiner H L
Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals.
Journal of neuroimmunology 1987;14(2):205-19.
1987: Brown R H; Johnson D; Ogonowski M; Weiner H L
Type 1 human poliovirus binds to human synaptosomes.
Annals of neurology 1987;21(1):64-70.
1987: Morimoto C; Hafler D A; Weiner H L; Letvin N L; Hagan M; Daley J; Schlossman S F
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
The New England journal of medicine 1987;316(2):67-72.
1986: Hafler D A; Fox D A; Benjamin D; Weiner H L
Antigen reactive memory T cells are defined by Ta1.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(2):414-8.
1986: Hauser S L; Bhan A K; Gilles F; Kemp M; Kerr C; Weiner H L
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
Annals of neurology 1986;19(6):578-87.
1986: Hafler D A; Fallis R J; Dawson D M; Schlossman S F; Reinherz E L; Weiner H L
Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12.
Neurology 1986;36(6):777-84.
1986: Dichter M A; Weiner H L; Fields B N; Mitchell G; Noseworthy J; Gaulton G; Greene M
Antiidiotypic antibody to reovirus binds to neurons and protects from viral infection.
Annals of neurology 1986;19(6):555-8.
1986: Brown R H; Hauser S L; Harrington H; Weiner H L
Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis.
Archives of neurology 1986;43(4):383-4.
1986: Hafler D A; Johnson D; Kelly J J; Panitch H; Kyle R; Weiner H L
Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics.
Neurology 1986;36(1):75-8.
1986: Levin L A; Weiner H L
Antigen presentation by astrocytes--a commentary.
The Journal of molecular and cellular immunology : JMCI 1986;2(5):281-2.
1985: Hauser S L; Ault K A; Johnson D; Hoban C; Weiner H L
Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset.
Clinical immunology and immunopathology 1985;37(3):312-23.
1985: Hafler D A; Hemler M E; Christenson L; Williams J M; Shapiro H M; Strom T B; Strominger J L; Weiner H L
Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases.
Clinical immunology and immunopathology 1985;37(2):163-71.
1985: Hafler D A; Buchsbaum M; Weiner H L
Decreased autologous mixed lymphocyte reaction in multiple sclerosis.
Journal of neuroimmunology 1985;9(6):339-47.
1985: Hafler D A; Buchsbaum M; Johnson D; Weiner H L
Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis.
Annals of neurology 1985;18(4):451-8.
1985: Hafler D A; Fox D A; Manning M E; Schlossman S F; Reinherz E L; Weiner H L
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
The New England journal of medicine 1985;312(22):1405-11.
1984: Hauser S L; Bahn A K; Che M; Gilles F; Weiner H L
Redistribution of Lyt-bearing T cells in acute murine experimental allergic encephalomyelitis: selective migration of Lyt-1 cells to the central nervous system is associated with a transient depletion of Lyt-1 cells in peripheral blood.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(6):3037-42.
1984: Hauser S L; Weiner H L; Bhan A K; Shapiro M E; Che M; Aldrich W R; Letvin N L
Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2288-90.
1984: Dichter M A; Weiner H L
Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism.
Annals of neurology 1984;16(5):603-10.
1984: Epstein R L; Finberg R; Powers M L; Weiner H L
Interaction of reovirus with cell surface receptors. IV. The reovirus type 3 receptor is expressed predominantly on murine Lyt-2,3+ and human T8+ cells.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(3):1614-7.
1984: Hauser S L; Fosburg M; Kevy S V; Weiner H L
Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects.
Neurology 1984;34(7):922-6.
1984: Tardieu M; Powers M L; Hafler D A; Hauser S L; Weiner H L
Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes.
European journal of immunology 1984;14(6):561-5.
1984: Weiner H L; Hafler D A; Fallis R J; Johnson D; Ault K A; Hauser S L
Altered blood T-cell subsets in patients with multiple sclerosis.
Journal of neuroimmunology 1984;6(2):115-21.
1984: Hauser S L; Weiner H L; Che M; Shapiro M E; Gilles F; Letvin N L
Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(3):1276-81.
1984: Epstein R L; Powers M L; Rogart R B; Weiner H L
Binding of 125I-labeled reovirus to cell surface receptors.
Virology 1984;133(1):46-55.
1984: Weiner H L; Hafler D A; Fallis R J; Johnson D; Ault K A; Hauser S L
T cell subsets in patients with multiple sclerosis. An overview.
Annals of the New York Academy of Sciences 1984;436():281-93.
1984: Weiner H L; Hauser S L; Hafler D A; Fallis R J; Lehrich J R; Dawson D M
The use of cyclophosphamide in the treatment of multiple sclerosis.
Annals of the New York Academy of Sciences 1984;436():373-81.
1983: Weiner H L; Ellison G W
A working protocol to be used as a guideline for trials in multiple sclerosis.
Archives of neurology 1983;40(11):704-10.
1983: Hauser S L; Bhan A K; Gilles F H; Hoban C J; Reinherz E L; Schlossman S F; Weiner H L
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen.
Journal of neuroimmunology 1983;5(2):197-205.
1983: Weiner H L; Dau P; Birnbaum G; Feldstein M; Khatri B; Petajan J; McQuillen M P
Plasma exchange in acute multiple sclerosis. Design of a cooperative study.
Archives of neurology 1983;40(11):691-2.
1983: Hauser S L; Dawson D M; Lehrich J R; Beal M F; Kevy S V; Weiner H L
Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
Archives of neurology 1983;40(11):687-90.
1983: Tardieu M; Noseworthy J H; Perry L; Che M; Greene M I; Weiner H L
Generation of a monoclonal antibody (Epenl) which binds selectively to murine ependymal cells.
Brain research 1983;277(2):339-46.
1983: Crary B; Hauser S L; Borysenko M; Kutz I; Hoban C; Ault K A; Weiner H L; Benson H
Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(3):1178-81.
1983: Tardieu M; Powers M L; Weiner H L
Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors.
Annals of neurology 1983;13(6):602-7.
1983: Hauser S L; Reinherz E L; Hoban C J; Schlossman S F; Weiner H L
CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets.
Neurology 1983;33(5):575-9.
1983: Hauser S L; Reinherz E L; Hoban C J; Schlossman S F; Weiner H L
Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.
Annals of neurology 1983;13(4):418-25.
1983: Hauser S L; Dawson D M; Lehrich J R; Beal M F; Kevy S V; Propper R D; Mills J A; Weiner H L
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
The New England journal of medicine 1983;308(4):173-80.
1983: Weiner H L; Hauser S L
Immunoregulation in multiple sclerosis.
Progress in brain research 1983;59():339-43.
1982: Weiner H L; Hauser S L
Neuroimmunology. II: Antigenic specificity of the nervous system.
Annals of neurology 1982;12(6):499-509.
1982: Hauser S L; Ropper A H; Perlo V P; Reinherz E L; Schlossman S F; Weiner H L
T-cell subsets in human autoimmune diseases.
Neurology 1982;32(11):1320-1.
1982: Hauser S L; Bresnan M J; Reinherz E L; Weiner H L
Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity.
Annals of neurology 1982;11(5):463-8.
1982: Weiner H L; Hauser S L
Neuroimmunology I: Immunoregulation in neurological disease.
Annals of neurology 1982;11(5):437-49.
1982: Hauser S L; Weiner H L; Ault K A
Clonally restricted B cells in peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns.
Annals of neurology 1982;11(4):408-12.
1982: Nepom J T; Weiner H L; Dichter M A; Tardieu M; Spriggs D R; Gramm C F; Powers M L; Fields B N; Greene M I
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells.
The Journal of experimental medicine 1982;155(1):155-67.
1982: Nepom J T; Tardieu M; Epstein R L; Noseworthy J H; Weiner H L; Gentsch J; Fields B N; Greene M I
Virus-binding receptors: similarities to immune receptors as determined by anti-idiotypic antibodies.
Survey of immunologic research 1982;1(3):255-61.
1982: Hauser S L; Fosburg M; Kevy S; Weiner H L
Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Progress in clinical and biological research 1982;106():239-54.
1981: Epstein R L; Powers M L; Weiner H L
Interaction of reovirus with cell surface receptors. III. Reovirus type 3 induces capping of viral receptors on murine lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(5):1800-3.
1981: Rubin D; Weiner H L; Fields B N; Greene M I
Immunologic tolerance after oral administration of reovirus: requirement for two viral gene products for tolerance induction.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(4):1697-701.
1981: Hauser S L; Ault K A; Levin M J; Garovoy M R; Weiner H L
Natural killer cell activity in multiple sclerosis.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(3):1114-7.
1981: Finberg R; Weiner H L; Burakoff S J; Fields B N
Type-specific reovirus antiserum blocks the cytotoxic T-cell-target cell interaction: evidence for the association of the viral hemagglutinin of a nonenveloped virus with the cell surface.
Infection and immunity 1981;31(2):646-9.
1980: Fontana A; Weiner H L
Interaction of reovirus with cell surface receptors. II. Generation of suppressor T cells by the hemagglutinin of reovirus type 3.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(6):2660-4.
1980: Weiner H L; Dawson D M
Plasmapheresis in multiple sclerosis: preliminary study.
Neurology 1980;30(10):1029-33.
1980: Reinherz E L; Weiner H L; Hauser S L; Cohen J A; Distaso J A; Schlossman S F
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.
The New England journal of medicine 1980;303(3):125-9.
1980: Greene M I; Weiner H L
Delayed hypersensitivity in mice infected with reovirus. II. Induction of tolerance and suppressor T cells to viral specific gene products.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(1):283-7.
1980: Weiner H L; Greene M I; Fields B N
Delayed hypersensitivity in mice infected with reovirus. I. Identification of host and viral gene products responsible for the immune response.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(1):278-82.
1980: Weiner H L; Ault K A; Fields B N
Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(5):2143-8.
1980: Weiner H L; Powers M L; Fields B N
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin.
The Journal of infectious diseases 1980;141(5):609-16.
1980: Fields B N; Weiner H L; Drayna D T; Sharpe A H
The role of the reovirus hemagglutinin in viral virulence.
Annals of the New York Academy of Sciences 1980;354():125-34.
1979: Weiner H L; Schocket A L
Lymphocytes in multiple sclerosis: correlation with CSF immunoglobulins and cold-reactive lymphocytotoxic antibodies.
Neurology 1979;29(11):1504-8.
1979: Hauser S L; Weiner H L; Bresnan M J; Ault K A
Lymphocyte capping in muscular dystrophy.
Neurology 1979;29(10):1419-21.
1979: Wechsler S L; Weiner H L; Fields B N
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.
Journal of immunology (Baltimore, Md. : 1950) 1979;123(2):884-9.
1979: Ault K A; Weiner H L
Natural killing of measles-infected cells by human lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(6):2611-6.
1979: Finberg R; Weiner H L; Fields B N; Benacerraf B; Burakoff S J
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(1):442-6.
1978: Ault K A; Weiner H L
Isolation and characterization of the class of human blood lymphocytes responsible for antibody-dependent cellular cytotoxicity.
Clinical immunology and immunopathology 1978;11(1):60-76.
1978: Scribner D J; Weiner H L; Moorhead J W
Anti-immunoglobulin stimulation of murine lymphocytes. V. Age-related decline in Fc receptor-mediated immunoregulation.
Journal of immunology (Baltimore, Md. : 1950) 1978;121(1):377-82.
1978: Weiner H L; Scribner D J; Moorhead J W
Anti-immunoglobulin stimulation of murine lymphocytes. IV. Re-expression and fate of cell surface receptors during stimulation.
Journal of immunology (Baltimore, Md. : 1950) 1978;120(6):1907-12.
1978: Weiner H L; Ramig R F; Mustoe T A; Fields B N
Identification of the gene coding for the hemagglutinin of reovirus.
Virology 1978;86(2):581-4.
1978: Weiner H L; Cherry J; McIntosh K
Decreased lymphocyte transformation to vaccinia virus in multiple sclerosis.
Neurology 1978;28(5):415-20.
1978: Weiner H L; Scribner D J; Schocket A L; Moorhead J W
Increased proliferative response of human peripheral blood lymphocytes to anti-immunoglobulin antibodies in elderly people.
Clinical immunology and immunopathology 1978;9(3):356-62.
1978: Schocket A L; Weiner H L
Lymphocytotoxic antibodies in family members of patients with multiple sclerosis.
Lancet 1978;1(8064):571-3.
1977: Scribner D J; Weiner H L; Moorhead J W
Surface immunoglobulin and Fc receptors on murine B lymphocytes: loss of receptor interaction after cell activation.
Journal of immunology (Baltimore, Md. : 1950) 1977;119(6):2084-8.
1977: Weiner H L; Drayna D; Averill D R; Fields B N
Molecular basis of reovirus virulence: role of the S1 gene.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(12):5744-8.
1977: Weiner H L; Fields B N
Neutralization of reovirus: the gene responsible for the neutralization antigen.
The Journal of experimental medicine 1977;146(5):1305-10.
1977: Weiner H L; Scribner D J; Moorhead J W
Anti-immunoglobulin stimulation of murine lymphocytes. III. Enhancement of the development of responsive B cells by thymic deprivation.
Cellular immunology 1977;31(1):77-84.
1977: Weiner H L; Schocket A L; Lehrich J R
Lymphocytotix antibodies in subacute sclerosing panencephalitis and amyotrophic lateral sclerosis.
Lancet 1977;1(8019):1013-4.
1977: Schocket A L; Weiner H L; Walker J; McIntosh K; Kohler P F
Lymphocytotoxic antibodies in multiple sclerosis.
Clinical immunology and immunopathology 1977;7(1):15-23.
1976: Weiner H L; Moorhead J W; Claman H N
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response.
Journal of immunology (Baltimore, Md. : 1950) 1976;116(6):1656-61.
1971: Weiner H L; Robinson W A
Leukopoietic activity in human urine following operative procedures.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;136(1):29-33.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Howard Weiner

Research Profile (preview)

Disorders

Living Beings

Anatomy

Physiology

Procedures

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Howard Weiner (preview)

All Publications